Purchase Order 36C24225P1211

Award Date 7/17/25
Potential Completion Date 8/16/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the delivery of TARPEYO 4mg (NDC 81749-0004-01), an emergency medical product, with a ceiling value of $10,896.98 and a period of performance ending on August 13, 2025. This contract does not have a...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG, a prescription medication, to the New York Harbor VA Medical Center. The contract has a ceiling value of $10,896.98 and an ultimate completion date of June 23, 2025. The contract does...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO 4mg capsules to the New York Harbor, Margaret Cochran Corbin VA Medical Center. The contract has a ceiling value of $10,896.98 and a period of performance ending on...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $10,896.98, is for the supply of TARPEYO 4MG (NDC 81749-0004-01), an emergency pharmaceutical product, to the VA's Veterans Integrated Service Network (VISN) 2. The contract has an ultimate completion date of July 30, 2025. Pantherx Specialty is the prime contractor,...
This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO 4MG, a specialized pharmaceutical product, to the VA's New York Harbor healthcare system. The contract has a ceiling value of $10,896.98 and a period of performance through July 31, 2025. The contract does not have a set-aside designation. Pantherx...
This federal contract award, valued at $10,897.20, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO (budesonide) 4mg prescription medication to the New York Harbor. The contract is a firm fixed-price purchase order with a completion date of May 28, 2025. This contract does not have a...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO (budesonide) 4mg prescription medication to the VA's Veterans Integrated Service Network (VISN) 2, which serves the New York Harbor region. The total ceiling value of the contract is $10,897.20, with a period of performance through May 2, 2025. The contract...
The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...

This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime contractor for this award, and there is no set-aside designation indicated. The contract supports the medical needs of veterans by providing specialized pharmaceutical products to federal healthcare systems.

Generated 7/18/25, 9:54 AM